BIOA — Bioiasis AD Income Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual income statement for Bioiasis AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.001 | 0 | 0 | 0 | 0.012 |
| Cost of Revenue | |||||
| Gross Profit | -0.033 | -0.039 | -0.029 | -0.033 | -0.051 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.061 | 0.075 | 0.075 | 0.079 | 0.114 |
| Operating Profit | -0.06 | -0.075 | -0.075 | -0.079 | -0.102 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.607 | -0.066 | -0.08 | 0.013 | -0.498 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.535 | -0.05 | -0.078 | 0.005 | -0.457 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.535 | -0.05 | -0.078 | 0.005 | -0.457 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.535 | -0.05 | -0.078 | 0.005 | -0.457 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.457 | -0.04 | -0.064 | 0.006 | -0.39 |